This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Upadhyay, S. Articles by Sidransky, D. Search for Related Content PubMed PubMed Citation Articles by Upadhyay, S. Articles by Sidransky, D.

LKB1/STK11 Suppresses Cyclooxygenase-2 Induction and Cellular Invasion through PEA3 in Lung Cancer

Departments of ¹ Otolaryngology-Head and Neck Surgery, ² Medicine, ³ Pathology, and ⁴ Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Requests for reprints: David Sidransky, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, 818 Ross Research Building, 720 Rutland Avenue, Baltimore, MD 21205-2196. Phone: 410-502-5153; Fax: 410-614-1411; E-mail: dsidrans{at}jhmi.edu.

We showed that the PEA3 transcriptional factor interacted with LKB1, a serine/threonine kinase, which is somatically mutated in lung cancer. This interaction occurred through the ETS domain of PEA3 and the kinase domain of LKB1. Mutation of LKB1 in lung cancer cells stabilized PEA3. Reintroduction of wild-type (WT) LKB1 into cells induced down-regulation of PEA3 and subsequently resulted in reduced cyclooxygenase-2 RNA and protein expression, whereas germ-line and somatic LKB1 mutants were defective in this activity. LKB1 phosphorylated PEA3 and promoted its degradation through a proteasome-mediated mechanism. Cells expressing mutant LKB1 possessed greater invasive potential compared with cells expressing WT LKB1. Increased invasion of cells with mutant LKB1 was partly due to PEA3 expression, as RNA interference inhibition of PEA3 resulted in dramatic decrease of Matrigel invasion. However, forced expression of PEA3 resulted in down-regulation of epithelial markers and induction of mesenchymal markers. These results suggest that PEA3 stabilization due to LKB1 inactivation could lead to epithelial/mesenchymal transition and greater lung cancer invasion potential. (Cancer Res 2006; 66(16): 7870-9)

This article has been cited by other articles:

				S. Rodriguez-Nieto and M. Sanchez-Cespedes BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer Carcinogenesis, April 1, 2009; 30(4): 547 - 554. [Abstract] [Full Text] [PDF]

				V. Firlej, F. Ladam, G. Brysbaert, P. Dumont, F. Fuks, Y. de Launoit, A. Benecke, and A. Chotteau-Lelievre Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription J. Cell Sci., October 15, 2008; 121(20): 3393 - 3402. [Abstract] [Full Text] [PDF]

				Y. Wei, D. Liu, Y. Ge, F. Zhou, J. Xu, H. Chen, J. Gu, and J. Jiang Identification of E1AF as a Target Gene of E2F1-induced Apoptosis in Response to DNA Damage J. Biochem., October 1, 2008; 144(4): 539 - 546. [Abstract] [Full Text] [PDF]

				S. Zhang, K. Schafer-Hales, F. R. Khuri, W. Zhou, P. M. Vertino, and A. I. Marcus The Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating cdc42 Recruitment and Activity Cancer Res., February 1, 2008; 68(3): 740 - 748. [Abstract] [Full Text] [PDF]